Meihua International faces significant headwinds as revenue contracted 16.2% YoY in 2025Q2, exacerbated by structural margin compression to 33.2% due to centralized procurement pressures. While the company maintains a conservative debt-to-equity ratio of 0.07,...
Price trend, volume and key moving averages
Trailing total returns as of 10/22/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Benchmark MHUA against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Meihua International Medical Technologies Co., Ltd. (MHUA)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $7.61 | $2.08M | 0.19 | -0.19% | 11.19% | 7.09% | — | |
| $9.68 | $109.2M | 26.16 | 30.75% | 17.63% | 8.32% | — | |
| $10.86 | $1.67B | -11.31 | 24.95% | -13.5% | -818.99% | — | |
| $1.87 | $205.75K | -0.19 | — | -227.72% | -25.53% | — | |
| $91.40 | $5.45B | 42.91 | 11.66% | 9.22% | 9.07% | — | |
| $15.59 | $1.81B | -12.78 | 8.28% | -21.25% | -44% | — |
Meihua International Medical Technologies Co., Ltd. (MHUA) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Get notified when MHUA posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Meihua International Medical Technologies Co., Ltd. (MHUA) stock FAQ — growth, dividends, profitability & financials explained
Meihua International Medical Technologies Co., Ltd. (MHUA) reported $183.8M in revenue for fiscal year 2024. This represents a 143% increase from $75.7M in 2018.
Meihua International Medical Technologies Co., Ltd. (MHUA) saw revenue decline by 0.2% over the past year.
Yes, Meihua International Medical Technologies Co., Ltd. (MHUA) is profitable, generating $18.6M in net income for fiscal year 2024 (11.2% net margin).
Meihua International Medical Technologies Co., Ltd. (MHUA) has a return on equity (ROE) of 7.1%. This is below average, suggesting room for improvement.
Meihua International Medical Technologies Co., Ltd. (MHUA) generated $12.1M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
